â– LECTURE OVERVIEW: Late pregnancy bleeding (after 20 weeks gestation) is a major clinical concern, most commonly caused by Placenta Previa or Placental Abruption.
â– PATHOPHYSIOLOGIC DIFFERENCES:
1. Placenta Previa (Abnormal Implantation):
- Definition: The placenta implants abnormally low in the segment, partially or completely covering the internal cervical os.
- Presentation: Manifests as painless, sudden, bright red vaginal bleeding. Bleeding occurs when cervical effacement tears the low-lying placental attachments.
2. Placental Abruption (Premature Separation):
- Definition: The premature detachment of a normally implanted placenta from the uterine wall prior to delivery.
- Presentation: Manifests as painful, dark vaginal bleeding accompanied by severe back pain, uterine contractions, and a rigid, tender uterus.
- Risk Factors: Chronic hypertension, preeclampsia, cocaine use, and abdominal trauma.
â– IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
â– MOLECULAR PATHWAY DYNAMICS:
Intracellular cascades undergo profound modifications, altering secondary transcription levels and receptor presentation on cellular membranes.
[HY-BOARD-1076]
🌟 Dynamic Clinical Key:
In cases of suspected placenta previa, digital vaginal exams are strictly contraindicated. Inserting a finger can tear placental vessels over the internal os, triggering catastrophic maternal-fetal hemorrhage. Diagnosis must be confirmed via transabdominal or transvaginal ultrasound first. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Therapeutic molecules targeting upstream signaling components demonstrate superior efficacy profiles.